Sort
30,917 grants matching “tumor microenvironment”
Exosome secretion in breast cancer progression
$444,905Alissa M Weaver · Vanderbilt University · R01 · FY2022 · CA
Identifying intercellular circuits driving cell phenotypes within a niche
$444,899Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Animal & Tissue Imaging Shared Resource
$444,876Lloyd C Trotman · Cold Spring Harbor Laboratory · P30 · FY2024 · CA
The role of GPR133 in glioblastoma
$444,858Dimitris G. Placantonakis · New York University School Of Medicine · R01 · FY2021 · NS
The role of GPR133 in glioblastoma
$444,858Dimitris G. Placantonakis · New York University School Of Medicine · R01 · FY2022 · NS
NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy Resistance
$444,852Albert Hong-Jae Kim · Washington University · R01 · FY2023 · NS
Improving genetically engineered T cells for medulloblastomas
$444,775Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2021 · NS
Improving genetically engineered T cells for medulloblastomas
$444,775Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2023 · NS
Improving genetically engineered T cells for medulloblastomas
$444,775Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2025 · NS
Improving genetically engineered T cells for medulloblastomas
$444,775Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2022 · NS
Discovery of novel PCFT-targeted agents
$444,742Larry H. Matherly · Wayne State University · R01 · FY2014 · CA
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$444,653Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2021 · CA
Improving treatment of HER2+ breast cancer brain metastasis by targeting lipid metabolism
$444,607Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2024 · CA
Modeling immunity with a hybrid lymph node tissue-chip
$444,594Rebecca R Pompano · University Of Virginia · R01 · FY2019 · AI
Using patient-derived co-culture models of breast cancer to develop new treatment strategies targeting succinate signaling.
$444,569Taru Eliisa Muranen · Beth Israel Deaconess Medical Center · R21 · FY2024 · CA
Administrative Core
$444,526Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2022 · AI
Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells
$444,510Dean G Tang · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA
Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)
$444,504Ajit Harishkumar Goenka · Mayo Clinic Rochester · R01 · FY2024 · CA
Epigenetic Regulation of Head and Neck Cancer Immune Evasion
$444,406Chao Lu · Columbia University Health Sciences · R01 · FY2024 · DE
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$444,359Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
The effect of oxygen gradients on sarcoma invasiveness through dynamic collagen modulation
$444,332Sharon Gerecht · Johns Hopkins University · U54 · FY2019 · CA
An In Situ Patient-specific Chemo-Immunotherapy for Skin Cancers
$444,330Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2014 · CA
Exploiting the immunomodulatory effects of sulindac and novel non-COX inhibitory derivatives for cancer treatment
$444,328Gang Zhou · Augusta University · R01 · FY2020 · CA
Fatty Acid Synthase:Molecular Target for Breast Cancer Therapy & Chemoprevention
$444,316Ruth Lupu · Mayo Clinic Rochester · R01 · FY2009 · CA
Dynamic Imaging for EMT in Breast Cancer Microenvironment
$444,273Christopher H Contag · Michigan State University · R01 · FY2017 · CA